YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2022Treatment of advanced heart failure JOURNAL OF THE KOREAN MEDICAL ASSOCIATION(대한의사협회지)
2022Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast CancerNEW ENGLAND JOURNAL OF MEDICINE
2022Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Final overall survival (OS) results from a randomized, multicenter, open-label, phase 2 study (DESTINY-Gastric01)JOURNAL OF CLINICAL ONCOLOGY
2022The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report ESMO OPEN
2022The risk of uterine cervical cancer in inflammatory bowel disease: An updated systematic review and meta-analysisANNALS OF ONCOLOGY
2022The Prognostic Value of Residual Nonrectal Inflammation in Ulcerative Colitis GUT AND LIVER
2022Telisotuzumab vedotin (Teliso-V) in combination with osimertinib in patients with advanced EGFR-mutated, c-met overexpressing, non-small cell lung cancer (NSCLC): Safety and efficacy results from phase Ib studyANNALS OF ONCOLOGY
2022Suggestion of cystatin C indication using muscle mass-based parameter for the desirable prediction of glomerular filtration rateCLINICA CHIMICA ACTA
2022Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR studyBRITISH JOURNAL OF HAEMATOLOGY
2022Stable disease (SD) on amivantamab in post-platinum epidermal growth factor receptor (EGFR) exon 20 insertion (Exon20ins) mutated non-small cell lung cancer (NSCLC): A response-based analysisANNALS OF ONCOLOGY
2022SOLUTION study: Effect of gemigliptin as add-on therapy to dapagliflozin plus metformin in patients with type 2 diabetesDIABETES RESEARCH AND CLINICAL PRACTICE
2022Smad4 and p53 synergize in suppressing autochthonous intestinal cancer CANCER MEDICINE
2022SKYSCRAPER-07: A phase III, randomized, double-blind, placebo-controlled study of atezolizumab with or without tiragolumab in patients with unresectable ESCC who have not progressed following definitive concurrent chemoradiotherapyJOURNAL OF CLINICAL ONCOLOGY
2022Sarcopenia is associated with cardiovascular risk in patients with COPD, independent of adiposityEUROPEAN RESPIRATORY JOURNAL
2022Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B HEPATOLOGY COMMUNICATIONS
2022RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS FLARES ACCORDING TO THE POSITIVITY OF AUTOANTIBODIESANNALS OF THE RHEUMATIC DISEASES
2022Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)ANNALS OF ONCOLOGY
2022Risk of metabolic syndrome and fatty liver in gastric cancer survivors: A propensity score-matched analysisJOURNAL OF CLINICAL ONCOLOGY
2022Response to Liao et al.AMERICAN JOURNAL OF GASTROENTEROLOGY
2022Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Final analysis of the prospective, observational REFINE studyANNALS OF ONCOLOGY
1 50 5152535455565758596061 691

Recent Submissions

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links